NCT03615326 2025-12-11
MK-3475-811
Merck Sharp & Dohme LLC
Phase 3 Completed
Clinical Trials
16 trialsNCT03013010 2025-12-08
PREACT
Shanghai Cancer Hospital, China
Phase 3 Completed
NCT01515748 2023-12-13
PRODIGY
Sanofi
Phase 3 Completed
NCT02114359 2020-10-23
Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer
Seoul National University Hospital
Phase 3 Completed
NCT02813967 2020-09-16
S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal Cancer
Zhejiang Cancer Hospital
Phase 3 Completed
NCT00915382 2020-01-07
Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOS
Asan Medical Center
Phase 3 Completed
NCT00770874 2019-06-21
Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical Cancer
Taiho Pharmaceutical Co., Ltd.
Phase 3 Completed
NCT02182778 2019-02-21
GEM/Cisplatin/S-1 vs GEM/Cisplatin for Biliary Tract Cancer
Kansai Hepatobiliary Oncology Group
Phase 3 Completed
NCT01824459 2019-01-23
S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients
Sun Yat-sen University
Phase 3 Completed
NCT01918852 2018-03-14
SALTO
Dutch Colorectal Cancer Group
Phase 3 Completed
NCT00660894 2016-08-03
Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Phase 3 Completed
NCT01671449 2015-11-30
SOPP
Asan Medical Center
Phase 3 Completed
NCT00677443 2013-06-14
Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer
Samsung Medical Center
Phase 3 Completed
NCT00152217 2011-07-07
Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)
Taiho Pharmaceutical Co., Ltd.
Phase 3 Completed
NCT00202969 2011-07-07
Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer
Taiho Pharmaceutical Co., Ltd.
Phase 3 Completed
NCT00287768 2011-06-28
Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer
Japan Clinical Cancer Research Organization
Phase 3 Completed